Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

VERIFI: A Multicenter, Case-Control Clinical Validation Study of the Multiplex Blood Protein Biomarker Test, PancreaSure, for Early Detection of Pancreatic Ductal Adenocarcinoma (PDAC) in High-Risk Patients

NCT06947395 is registered in ClinicalTrials.gov with Immunovia, Inc. as lead sponsor.

NCT NCT06947395
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06947395 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
VERIFI: A Multicenter, Case-Control Clinical Validation Study of the Multiplex Blood Protein Biomarker Test, PancreaSure, for Early Detection of Pancreatic Ductal Adenocarcinoma (PDAC) in High-Risk Patients
Lead sponsor
Immunovia, Inc.
Phase
Observational
Overall status
Completed
Start date
February 11, 2025
Completion date
April 7, 2025
Enrollment
386 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

cancer of the pancreas, pancreas neoplasms, pancreatic cancer, pancreatic carcinoma stage i, pancreatic carcinoma stage ii